StpC-based gene therapy targeting latent reservoirs of HIV-1

Antiviral Research

Volumn 72, Issue 3, 2006, Pages 233-241

  Turner, Lorianne Stehouwer ^a   Tsygankov, Alexander Y ^a   Henderson, Earl E ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Herpesvirus saimiri; HIV 1; Latency; Lentiviral vector; StpC; Suicide gene

Indexed keywords

C SAIMIRI TRANSFORMATION ASSOCIATED PROTEIN; GANCICLOVIR; THYMIDINE KINASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CEBIDAE; CELL PROLIFERATION; CYTOMEGALOVIRUS; DRUG SENSITIZATION; GENE EXPRESSION REGULATION; GENE TARGETING; HERPES SIMPLEX VIRUS; HERPES VIRUS SAIMIRI; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENTIVIRUS VECTOR; LONG TERMINAL REPEAT; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SUICIDE GENE THERAPY; VIRAL GENE THERAPY; VIRUS LATENCY; VIRUS REPLICATION;

ANTI-HIV AGENTS; CELL LINE; CYTOMEGALOVIRUS; GANCICLOVIR; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HIV CORE PROTEIN P24; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; LENTIVIRUS; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); PROVIRUSES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SIMPLEXVIRUS; THYMIDINE KINASE; VIRAL PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SAIMIRI; SAIMIRIINE HERPESVIRUS 2; SIMPLEXVIRUS; SUBGROUP C;

EID: 33750721630     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.06.010     Document Type: Article

References (68)

1. Biancotto A., Grivel J.-C., Gondois-Rey F., Bettendroffer L., Vigne R., Brown S., Margolis L.B., and Hirsch I. Dual role of Prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue. J. Virol. 78 (2004) 10507-10515
2. Biesinger B., Muller-Fleckenstein I., Simmer B., Lang G., Wittman S., Platzer E., Desrosiers R.C., and Fleckenstein B. Stable growth transformation of human T lymphocytes by Herpesvirus saimiri. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 3116-3119
3. Blankson J.N., Persaud D., and Siliciano R.F. The challenge of viral reservoirs in HIV-1 infection. Annu. Rev. Med. 53 (2002) 557-593
4. Borrelli E., Heyman R., Hsi M., and Evans R.M. Targeting of an inducible toxic phenotype in animal cells. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 7572-7576
5. Brady H.J., Miles C.G., Pennington D.J., and Dzierzak E.A. Specific ablation of human immunodeficiency virus Tat-expressing cells by conditionally toxic retroviruses. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 365-369
6. Brenchley J.M., Hill B.J., Ambrozak D.R., Price D.A., Guenaga F.J., Casazza J.P., Kuruppu J., Yazdani J., Migueles S.A., Connors M., Roederer M., Douek D.C., and Koup R.A. T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J. Virol. 78 (2004) 1160-1168
7. Broker B., Tsygankov A., Muller-Fleckenstein I., Guse A., Chitaev N., Biesinger B., Fleckenstein B., and Emmrich F. Immortalization of human T cell clones by Herpesvirus saimiri. Signal transduction analysis reveals functional CD3, CD4, and IL-2 receptors. J. Immunol. 151 (1993) 1184-1192
8. Brooks D.G., Arlen P.A., Gao L., Kitchen C.M.R., and Zack J.A. Identification of T cell-signaling pathways that stimulate latent HIV in primary cells. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 12955-12960
9. Browning J., Horner J.W., Pettoello-Mantovani M., Raker C., Yurasov S., DePinho R.A., and Goldstein H. Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 14637-14641
10. Butera S.T., Roberts B.D., Lam L., Hodge T., and Folks T.M. Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency. J. Virol. 68 (1994) 2726-2730
11. + cells harboring a human immunodeficiency virus-inducible suicide gene prevents viral spread in an infected cell population. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 182-186
12. Caselli E., Galvan M., Cassai E., Caruso A., Sighinolfi L., and Di Luca D. Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells. Blood 106 (2005) 2790-2797
13. Caselli E., Galvan M., Santoni F., Rotola A., Caruso A., Cassai E., and Luca D.D. Human herpesvirus-8 (Kaposi's sarcoma-associated virus) ORF50 increases in vitro cell susceptibility to human immunodeficiency virus type 1 infection. J. Gen. Virol. 84 (2003) 1123-1131
14. Cavert W., Notermans D.W., Staskus K., Wietgrefe S.W., Zupancic M., Gebhard K., Henry K., Zhang Z.-Q., Mills R., McDade H., Goudsmit J., Danner S.A., and Haase A.T. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 276 (1997) 960-964
15. Chenciner N., Pedroza Martins L., Hanania N., Stratford Perricaudet L., Perricaudet M., and Wain-Hobson S. Residual expression of reporter genes in constructs mimicking HIV genome organization. Res. Virol. 146 (1995) 171-178
16. Chun T.W., Carruth L., Finzi D., Shen X., DiGiuseppe J.A., Taylor H., Hermankova M., Chadwick K., Margolick J., Quinn T.C., Kuo Y.-H., Brookmeyer R., Zeiger M.A., Barditch-Crovo P., and Siliciano R.F. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387 (1997) 183-187
17. + T cells using a combination of cytokines. J. Exp. Med. 188 (1998) 83-91
18. Chun T.W., Stuyver L., Mizell S.B., Ehler L.A., Mican J.M., Baseler M., Lloyd A.L., Nowak M.A., and Fauci A.S. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 13193-13197
19. Cole S.W., Naliboff B.D., Kemeny M.E., Griswold M.P., Fahey J.L., and Zack J.A. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12695-12700
20. Demonte D., Quivy V., Colette Y., and Van Lint C. Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs: implications for the development of therapeutic strategies. Biochem. Pharmacol. 68 (2004) 1231-1238
21. Duboise S.M., Guo J., Czajak S., Desrosiers R.C., and Jung J.U. STP and Tip are essential for herpesvirus saimiri oncogenicity. J. Virol. 72 (1998) 1308-1313
22. Fickenscher H., and Fleckenstein B. Herpesvirus saimiri. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 356 (2001) 545-567
23. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5 (1999) 512-517
24. Finzi D., Hermankova M., Pierson T., Carruth L.M., Buck C., Chaisson R.E., Quinn T.C., Chadwick K., Margolick J., Brookmeyer R., Gallant J., Markowitz M., Ho D.D., Richman D.D., and Siliciano R.F. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278 (1997) 1295-1300
25. Fujinaga K., Zhong Q., Nakaya T., Kameoka M., Meguro T., Yamada K., and Ikuta K. Extracellular Nef protein regulates productive HIV-1 infection from latency. J. Immunol. 155 (1995) 5289-5298
26. + T lymphocytes by combination of cytokines. J. Virol. 75 (2001) 11336-11343
27. Hasham M.G., and Tsygankov A.Y. Tip, an Lck-interacting protein of Herpesvirus saimiri, causes Fas- and Lck-dependent apoptosis of T lymphocytes. Virology 320 (2004) 313-329
28. Henderson E.E., Tsygankov A.Y., Merlo J.J., Romano G., and Guan M. Altered replication of human immunodeficiency virus type 1 (HIV-1) in T cell lines retrovirally transduced to express Herpesvirus saimiri proteins StpC and/or Tip. Virology 264 (1999) 125-133
29. Jung J.U., and Desrosiers R.C. Association of the viral oncoprotein STP-C488 with cellular ras. Mol. Cell. Biol. 15 (1995) 6506-6512
30. Jung J.U., Trimble J.J., King N.W., Biesinger B., Fleckenstein B.W., and Desrosiers R.C. Identification of transforming genes of subgroup A and C strains of Herpesvirus saimiri. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7051-7055
31. Karn J. Tackling Tat. J. Mol. Biol. 293 (1999) 235-254
32. + T cells isolated from HIV-infected individuals in the absence of markers of cellular activation or apoptosis. J. Immunol. 170 (2003) 2449-2455
33. Korin Y.D., Brooks D.G., Brown S., Korotzer A., and Zack J.A. Effects of Prostratin on T-cell activation and human immunodeficiency virus latency. J. Virol. 76 (2002) 8118-8123
34. Kulkosky J., Culnan D.M., Roman J., Dornadula G., Schnell M., Boyd M.R., and Pomerantz R.J. Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. Blood 98 (2001) 3006-3015
35. + T cells in vivo. J. Virol. 78 (2004) 9105-9114
36. Lee H., Choi J.K., Li M., Kaye K., Kieff E., and Jung J.U. Role of cellular tumor necrosis factor receptor-associated factors in NF-kappaB activation and lymphocyte transformation by herpesvirus Saimiri STP. J. Virol. 73 (1999) 3913-3919
37. Lehrman G., Hogue I.B., Palmer S., Jennings C., Spina C.A., Wiegand A., Landay A.L., Coombs R.W., Richman D.D., Mellors J.W., Coffin J.M., Bosch R.J., and Margolis D.M. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet 366 (2005) 549-555
38. Lin X., Kanazawa S., Huang L., Romeo J., Yen T.S.B., and Peterlin B.M. Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir. J. Virol. 77 (2003) 8227-8236
39. Marcello A., and Giaretta I. Inducible expression of herpes simplex virus thymidine kinase from a bicistronic HIV1 vector. Res. Virol. 149 (1998) 419-431
40. Merlo J.J., and Tsygankov A.Y. Herpesvirus saimiri oncoproteins Tip and StpC synergistically stimulate NF-kappaB activity and interleukin-2 gene expression. Virology 279 (2001) 325-338
41. Miyake K., Iijima O., Suzuki N., Matsukura M., and Shimada T. Selective killing of human immunodeficiency virus-infected cells by targeted gene transfer and inducible gene expression using a recombinant human immunodeficiency virus vector. Hum. Gene Ther. 12 (2001) 227-233
42. Moolten F.L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res. 46 (1986) 5276-5281
43. Muesing M.A., Smith D.H., and Capon D.J. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 48 (1987) 691-701
44. Murphy C., Kretschmer C., Biesinger B., Beckers J., Jung J., Desrosiers R.C., Muller-Hermelink H.K., Fleckenstein B.W., and Ruther U. Epithelial tumours induced by a herpesvirus oncogene in transgenic mice. Oncogene 9 (1994) 221-226
45. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., and Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 (1996) 263-267
46. Nick S., Fickenscher H., Biesinger B., Born G., Gerhard J., and Fleckenstein B. Herpesvirus saimiri transformed human T cell lines: a permissive system for human immunodeficiency viruses. Virology 194 (1993) 875-877
47. Pati S., Foulke Jr. J.S., Barabitskaya O., Kim J., Nair B.C., Hone D., Smart J., Feldman R.A., and Reitz M. Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat. J. Virol. 77 (2003) 5759-5773
48. Pereira L.A., Bentley K., Peeters A., Churchill M.J., and Deacon N.J. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res. 28 (2000) 663-668
49. Perelson A.S., Essunger P., Cao Y., Vesanen M., Hurley A., Saksela K., Markowitz M., and Ho D.D. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387 (1997) 188-191
50. 2+ mobilization after CD3 stimulation. J. Immunol. 147 (1991) 3145-3148
51. Perkins N., Edwards N., Duckett C., Agranoff A., Schmid R., and Nabel G. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. EMBO J. 12 (1993) 3551-3558
52. Raymond A.D., Hasham M.G., Tsygankov A.Y., and Henderson E.E. Herpesvirus saimiri-encoded Tip and StpC proteins regulate human immunodeficiency virus 1 replication in T cell lines and primary lymphocytes independently of viral tropism. Virology 324 (2004) 60-66
53. Raymond, A.D., Tsygankov, A.Y., Henderson, E., Herpesvirus saimiri terminal membrane proteins modulate HIV-1 replication by altering Nef and Tat functions. Curr. HIV Res., in press.
54. Romano G., Guan M., Long W.K., and Henderson E.E. Differential effects on HIV-1 gene regulation by EBV in T lymphocytic and promonocytic cells transduced to express recombinant human CR2. Virology 237 (1997) 23-32
55. Rosen C.A., Sodroski J.G., and Haseltine W.A. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 41 (1985) 813-823
56. Salgame P., Varadhachary A.S., Primiano L.L., Fincke J.E., Muller S., and Monestier M. An ELISA for detection of apoptosis. Nucleic Acids Res. 25 (1997) 680-681
57. Scheller C., Sopper S., Chen P., Flory E., Koutsilieri E., Racek T., Ludwig S., terMeulen V., and Jassoy C. Caspase inhibition activates HIV in latently infected cells. J. Biol. Chem. 277 (2002) 15459-15464
58. Scripture-Adams D.D., Brooks D.G., Korin Y.D., and Zack J.A. Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype. J. Virol. 76 (2002) 13077-13082
59. Sorokina E.M., Merlo Jr. J.J., and Tsygankov A.Y. Molecular mechanisms of the effect of Herpesvirus saimiri protein StpC on the signaling pathway leading to NF-kappa B activation. J. Biol. Chem. 279 (2004) 13469-13477
60. Thust R., Tomicic M., Klöcking R., Voutilainen N., Wutzler P., and Kaina B. Comparison of the genotoxic and apoptosis-inducing properties of ganciclovir and penciclovir in Chinese hamster ovary cells transfected with the thymidine kinase gene of herpes simplex virus-1: implications for gene therapeutic approaches. Cancer Gene Ther. 7 (2000) 107-117
61. Tobiume M., Fujinaga K., Suzuki S., Komoto S., Mukai T., and Ikuta K. Extracellular Nef protein activates signal transduction pathway from Ras to mitogen-activated protein kinase cascades that leads to activation of human immunodeficiency virus from latency. AIDS Res. Hum. Retroviruses 18 (2002) 461-467
62. Tomicic M.T., Thust R., and Kaina B. Ganciclovir-induced apoptosis in HSV-1 thymidine kinase expressing cells: critical role of DNA breaks, Bcl-2 decline and caspase-9 activation. Oncogene 21 (2002) 2141-2153
63. Tsygankov A.Y. Cell transformation by Herpesvirus saimiri. J. Cell. Physiol. 203 (2005) 305-318
64. Wang F.-X., Xu Y., Sullivan J., Souder E., Argyris E.G., Acheampong E.A., Fisher J., Sierra M., Thomson M.M., Najera R., Frank I., Kulkosky J., Pomerantz R.J., and Nunnari G. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. J. Clin. Investig. 115 (2005) 128-137
65. West M.J., Lowe A.D., and Karn J. Activation of human immunodeficiency virus transcription in T cells revisited: NF-kB p65 stimulates transcriptional elongation. J. Virol. 75 (2001) 8524-8537
66. Wildin R., Garvin A., Pawar S., Lewis D., Abraham K., Forbush K., Ziegler S., Allen J., and Perlmutter R. Developmental regulation of lck gene expression in T lymphocytes. J. Exp. Med. 173 (1991) 383-393
67. Wong J.K., Hezareh M., Gunthard H.F., Havlir D.V., Ignacio C.C., Spina C.A., and Richman D.D. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278 (1997) 1291-1295
68. Ylisastigui L., Archin N.M., Lehrman G., Bosch R.J., and Margolis D.M. Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression. AIDS 18 (2004) 1101-1108